Health care stocks were higher Monday afternoon, with the NYSE Health Care Index rising 0.8% and the Health Care Select Sector SPDR Fund (XLV) up 0.6%.
The iShares Biotechnology ETF (IBB) added 0.3%.
In corporate news, Ikena Oncology (IKNA) and clinical-stage biotech company Inmagene Biopharmaceuticals said Monday they have agreed to merge, in a deal that will result in the latter owning about 43.5% of the combined company. Ikena shares surged 13%.
XBiotech (XBIT) shares sank past 27% after it said it's pausing its rheumatology clinical program due to irregularities in a phase 2 study of its candidate drug Natrunix for rheumatoid arthritis.
Spectral AI (MDAI) shares popped 10%. The company said Monday it received a letter from Nasdaq on Friday confirming that it has regained compliance with the exchange's listing rules.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。